Taro’s Merger Proposal At $15 A Share “Outrageous,” Sun Says; Extends Offer Deadline

MUMBAI - The war of words between Sun Pharmaceutical and Israeli drug maker Taro has intensified as the two companies exchange proposals and counter-proposals for a merger as directed by Israel's Supreme Court